Abaidullah N, Muhammad K, Waheed Y
AAPS PharmSciTech. 2025; 26(3):74.
PMID: 40038143
DOI: 10.1208/s12249-025-03063-1.
Aparna T, Kumar R, Ali S, Patel D, Julekha K, Begum T
AAPS PharmSciTech. 2025; 26(1):33.
PMID: 39806209
DOI: 10.1208/s12249-024-02982-9.
Zhang C, Yuan Y, Xia Q, Wang J, Xu K, Gong Z
Adv Sci (Weinh). 2025; 12(9):e2415902.
PMID: 39792782
PMC: 11884566.
DOI: 10.1002/advs.202415902.
Taheri Z, Mozafari N, Moradian G, Lovison D, Dehshahri A, De Marco R
Pharmaceutics. 2024; 16(11).
PMID: 39598564
PMC: 11597626.
DOI: 10.3390/pharmaceutics16111441.
Anees M, Gupta P, Kaur H, Kharbanda S, Singh H
AAPS PharmSciTech. 2024; 25(7):211.
PMID: 39242397
DOI: 10.1208/s12249-024-02918-3.
Theranostic Diagnostics.
Ali M, Chaudhary B, Panja S, Gendelman H
Results Probl Cell Differ. 2024; 73:551-578.
PMID: 39242393
DOI: 10.1007/978-3-031-62036-2_22.
Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy.
Guo Y, Lv T, Li Z, Wei X, Yang C, Li W
J Nanobiotechnology. 2024; 22(1):430.
PMID: 39033108
PMC: 11264854.
DOI: 10.1186/s12951-024-02719-7.
Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery.
Desai N, Rana D, Salave S, Benival D, Khunt D, Prajapati B
Molecules. 2024; 29(13).
PMID: 38999083
PMC: 11243486.
DOI: 10.3390/molecules29133131.
Biodynamer Nano-Complexes and -Emulsions for Peptide and Protein Drug Delivery.
Liu Y, Hamm T, Eichinger T, Kamm W, Wieland H, Loretz B
Int J Nanomedicine. 2024; 19:4429-4449.
PMID: 38784761
PMC: 11114140.
DOI: 10.2147/IJN.S448578.
Microenvironment of pancreatic inflammation: calling for nanotechnology for diagnosis and treatment.
Liu L, Zhang Y, Li X, Deng J
J Nanobiotechnology. 2023; 21(1):443.
PMID: 37996911
PMC: 10666376.
DOI: 10.1186/s12951-023-02200-x.
A Systematic Study of Anti-Osteosarcoma Mechanism of pH-Sensitive Charge-Conversion Cinnamaldehyde Polymeric Prodrug Micelles In Vitro.
Deng J, Wang Q, Xu H, Li G, Liu S, Chen Y
Biomedicines. 2023; 11(6).
PMID: 37371619
PMC: 10295571.
DOI: 10.3390/biomedicines11061524.
Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer.
Dang W, Xing B, Jia X, Zhang Y, Jia B, Yu C
Int J Nanomedicine. 2023; 18:3047-3068.
PMID: 37312934
PMC: 10259594.
DOI: 10.2147/IJN.S413680.
pH-sensitive charge-conversion cinnamaldehyde polymeric prodrug micelles for effective targeted chemotherapy of osteosarcoma .
Deng J, Liu S, Li G, Zheng Y, Zhang W, Lin J
Front Chem. 2023; 11:1190596.
PMID: 37206197
PMC: 10188981.
DOI: 10.3389/fchem.2023.1190596.
Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting.
Gyanani V, Goswami R
Pharmaceutics. 2023; 15(4).
PMID: 37111668
PMC: 10144967.
DOI: 10.3390/pharmaceutics15041184.
pH-triggered cancer-targeting polymers: From extracellular accumulation to intracellular release.
Khan R, Shao J, Liao J, Qian L
Nano Res. 2023; 16(4):5155-5168.
PMID: 36618069
PMC: 9807988.
DOI: 10.1007/s12274-022-5252-z.
Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications.
Sharma A, Lee Y, Bat-Ulzii A, Bhattacharya M, Chakraborty C, Lee S
J Nanobiotechnology. 2022; 20(1):501.
PMID: 36434667
PMC: 9700905.
DOI: 10.1186/s12951-022-01650-z.
Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
Zhou W, Jia Y, Liu Y, Chen Y, Zhao P
Pharmaceutics. 2022; 14(11).
PMID: 36365164
PMC: 9694300.
DOI: 10.3390/pharmaceutics14112346.
Overview of Physicochemical Properties of Nanoparticles as Drug Carriers for Targeted Cancer Therapy.
Yagublu V, Karimova A, Hajibabazadeh J, Reissfelder C, Muradov M, Bellucci S
J Funct Biomater. 2022; 13(4).
PMID: 36278665
PMC: 9590029.
DOI: 10.3390/jfb13040196.
pH-responsive targeted gold nanoparticles for photoacoustic imaging of tumor microenvironments.
Li S, Lui K, Tsoi T, Lo W, Li X, Hu X
Nanoscale Adv. 2022; 1(2):554-564.
PMID: 36132235
PMC: 9473232.
DOI: 10.1039/c8na00190a.
A New Class of Tunable Acid-Sensitive Linkers for Native Drug Release Based on the Trityl Protecting Group.
Timmers M, Weterings J, van Geijn M, Bell R, Lenting P, Rijcken C
Bioconjug Chem. 2022; 33(9):1707-1715.
PMID: 35979909
PMC: 9501768.
DOI: 10.1021/acs.bioconjchem.2c00310.